Preoperative antiplatelet therapy may be a risk factor for postoperative ischemic complications in intracranial hemorrhage patients

References

• van Asch CJ, Luitse MJ, Rinkel GJ, et al. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9(2):167–176.
   PubMed Web of Science ®Google Scholar
• Luzzi S, Elia A, Del Maestro M, et al. Indication, timing, and surgical treatment of spontaneous intracerebral hemorrhage: systematic review and proposal of a management algorithm. World Neurosurg. 2019;124:e769–e778.
   Web of Science ®Google Scholar
• Qureshi AI, Mendelow AD, Hanley DF. Intracerebral haemorrhage. Lancet. 2009;373(9675):1632–1644.
   PubMed Web of Science ®Google Scholar
• Ozdemir B, Kanat A, Ozdemir V, et al. The effect of neuroscientists on the studies of autonomic nervous system dysfunction following experimental subarachnoid hemorrhage. J Craniofac Surg. 2019;30(7):2184–2188.
   PubMed Web of Science ®Google Scholar
• Kanat A, Tsianaka E, Gasenzer ER, et al. Some interesting points of competition of X-ray using during the Greco-Ottoman war in 1897 and development of neurosurgical radiology: a reminiscence. Turk Neurosurg. 2022;32(5):877–881.
   PubMed Web of Science ®Google Scholar
• Aydin MD, Kanat A, Aydin A, et al. Estimating basilar artery upper rupture limit by dangerous alarming ­diameter of arteries (DADA) following bilateral common carotid artery ligation; a new theorem. Int J Neurosci. 2022;132(2):107–113.
   PubMed Web of Science ®Google Scholar
• Wu J, Liu Q, Wang K, et al. Emergency surgery is an effective way to improve the outcome of severe spontaneous intracerebral hemorrhage patients on long-term oral antiplatelet therapy. Neurosurg Rev. 2021;44(2):1205–1216.
   PubMed Web of Science ®Google Scholar
• Yu S-X, Zhang Q-S, Yin Y, et al. Continuous monitoring of intracranial pressure for prediction of postoperative complications of hypertensive intracerebral hemorrhage. Eur Rev Med Pharmacol Sci. 2016;20(22):4750–4755.
   PubMed Web of Science ®Google Scholar
• Trialists’ A, Collaboration ATT, Baigent C, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373:1849–1860.
   PubMed Web of Science ®Google Scholar
• Burger W, Chemnitius J-M, Kneissl GD, et al. Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update. J Intern Med. 2005;257(5):399–414.
   PubMed Web of Science ®Google Scholar
• Lovelock C, Molyneux A, Rothwell P. Change in incidence and aetiology of intracerebral haemorrhage in oxfordshire, UK, between 1981 and 2006: a population-based study. Lancet Neurol. 2007;6(6):487–493.
   PubMed Web of Science ®Google Scholar
• Fiaschi P, Laccarino P, Stefini R, et al. Clinical practice for antiplatelet and anticoagulant therapy in neurosurgery: data from an italian survey and summary of current recommendations - part I, antiplatelet therapy. Neurosurg Rev. 2021;44(1):485–493.
   PubMed Web of Science ®Google Scholar
• Won S-Y, Dubinski D, Bruder M, et al. Acute subdural hematoma in patients on oral anticoagulant therapy: management and outcome. Neurosurg Focus. 2017;43(5):E12.
   PubMed Web of Science ®Google Scholar
• Uccella L, Zoia C, Bongetta D, et al. Are antiplatelet and anticoagulants drugs a risk factor for bleeding in ­mild traumatic brain injury? World Neurosurg. 2018;110:e339–e345.
   PubMed Web of Science ®Google Scholar
• Gregoire SM, Jäger HR, Yousry TA, et al. Brain microbleeds as a potential risk factor for antiplatelet-related intracerebral haemorrhage: hospital-based, case-control study. J Neurol Neurosurg Psychiatry. 2010;81(6):679–684.
   PubMed Web of Science ®Google Scholar
• Murthy SB, Diaz I, Wu X, et al. Risk of arterial ischemic events after intracerebral hemorrhage. Stroke. 2020;51(1):137–142.
   PubMed Web of Science ®Google Scholar
• Casolla B, Moulin S, Kyheng M, et al. Five-year risk of major ischemic and hemorrhagic events after intracerebral hemorrhage. Stroke. 2019;50(5):1100–1107.
   PubMed Web of Science ®Google Scholar
• Kothari RU, Brott T, Broderick JP, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke. 1996;27(8):1304–1305.
   PubMed Web of Science ®Google Scholar
• Hornor MA, Duane TM, Ehlers AP, et al. American college of surgeons’ guidelines for the perioperative management of antithrombotic medication. J Am Coll Surg. 2018;227(5):521–536.e1.
   PubMed Web of Science ®Google Scholar
• Cahill RA, McGreal GT, Crowe BH, et al. Duration of increased bleeding tendency after cessation of aspirin therapy. J Am Coll Surg. 2005;200(4):564–573. https://www.ncbi.nlm.nih.gov/pubmed/15804471.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, Biomarker Subcommittee ECG SubcommitteeImaging SubcommitteeIntervention SubcommitteeTrials & Registries SubcommitteeTrials & Registries SubcommitteeTrials & Registries SubcommitteeTrials & Registries SubcommitteeESC Committee for Practice Guidelines (CPG)Document ReviewersJoint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction, Authors/Task Force Members Chairpersons, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60(16):1581–1598.
   PubMed Web of Science ®Google Scholar
• Kanat A, Yazar U, Kazdal H. Chronic subdural hygroma with thrombocythemia: first case report. J Neurosurg Sci. 2009;53(4):165–167.
   PubMed Web of Science ®Google Scholar
• Devereaux PJ, Mrkobrada M, Sessler DI, POISE-2 Investigators, et al. Aspirin in patients undergoing noncardiac surgery. N Engl J Med. 2014;370(16):1494–1503.
   PubMed Web of Science ®Google Scholar
• Luni FK, Riaz H, Khan AR, et al. Clinical outcomes associated with per-operative discontinuation of aspirin in patients with coronary artery disease: a systematic review and meta-analysis. Catheter Cardiovasc Interv. 2017;89(7):1168–1175.
   PubMed Web of Science ®Google Scholar
• Wąsowicz M, Syed S, Wijeysundera DN, et al. Effectiveness of platelet inhibition on major adverse cardiac events in non-cardiac surgery after percutaneous coronary intervention: a prospective cohort study. Br J Anaesth. 2016;116(4):493–500.
   PubMed Web of Science ®Google Scholar
• Greuter L, Ullmann M, Mariani L, et al. Effect of preoperative antiplatelet or anticoagulation therapy on hemorrhagic complications in patients with traumatic brain injury undergoing craniotomy or craniectomy. Neurosurg Focus. 2019;47(5):E3.
   PubMed Web of Science ®Google Scholar
• Rahman M, Donnangelo LL, Neal D, et al. Effects of perioperative acetyl salicylic acid on clinical outcomes in patients undergoing craniotomy for brain tumor. World Neurosurg. 2015;84(1):41–47.
   PubMed Web of Science ®Google Scholar
• Hanalioglu S, Sahin B, Sahin OS, et al. Effect of perioperative aspirin use on hemorrhagic complications in elective craniotomy for brain tumors: results of a single-center, retrospective cohort study. J Neurosurg. 2019;132(5):1529–1538.
   PubMed Web of Science ®Google Scholar
• Stein M, Misselwitz B, Hamann GF, et al. In-hospital mortality after pre-treatment with antiplatelet agents or oral anticoagulants and hematoma evacuation of intracerebral hematomas. J Clin Neurosci. 2016;26:42–45.
   PubMed Web of Science ®Google Scholar
• Franco L, Paciaroni M, Enrico ML, et al. Mortality in patients with intracerebral hemorrhage associated with antiplatelet agents, oral anticoagulants or no antithrombotic therapy. Eur J Intern Med. 2020;75:35–43.
   PubMed Web of Science ®Google Scholar
• Liu Z-H, Chen N-Y, Tu P-H, et al. Previous antithrombotic therapy, particularly anticoagulant, is associated with unfavorable outcomes in patients with primary spontaneous intracerebral hemorrhage receiving craniotomy: a nationwide population-based cohort study. World Neurosurg. 2019;128:e59–e73.
   PubMed Web of Science ®Google Scholar
• Ford I. Coming safely to a stop: a review of platelet activity after cessation of antiplatelet drugs. Ther Adv Drug Saf. 2015;6(4):141–150.
   PubMedGoogle Scholar
• Hybiak J, Broniarek I, Kiryczyński G, et al. Aspirin and its pleiotropic application. Eur J Pharmacol. 2020;866:172762.
   PubMed Web of Science ®Google Scholar
• Ornelas A, Zacharias-Millward N, Menter DG, et al. Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention. Cancer Metastasis Rev. 2017;36(2):289–303.
   PubMed Web of Science ®Google Scholar
• Angiolillo DJ, Rollini F, Storey RF, et al. International expert consensus on switching platelet P2Y12 Receptor-Inhibiting therapies. Circulation. 2017;136(20):1955–1975.
   PubMed Web of Science ®Google Scholar
• Patrono C, Morais J, Baigent C, et al. Antiplatelet agents for the treatment and prevention of coronary atherothrombosis. J Am Coll Cardiol. 2017;70(14):1760–1776.
   PubMed Web of Science ®Google Scholar
• von Kügelgen I. Pharmacology of P2Y receptors. Brain Res Bull. 2019;151:12–24.
   PubMed Web of Science ®Google Scholar
• Nascimento Silva JS, de Barros IML, Cantarelli FL, et al. Predictors of coronary stent thrombosis: a case-control study. J Thromb Thrombolysis. 2018;46(3):420–426.
   PubMed Web of Science ®Google Scholar
• Ho PM, Tsai TT, Wang TY, et al. Adverse events after stopping clopidogrel in post-acute coronary syndrome patients: insights from a large integrated healthcare delivery system. Circ: Cardiovasc Qual Outcomes. 2010;3(3):303–308.
   PubMed Web of Science ®Google Scholar
• Ho PM, Peterson ED, Wang L, et al. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA. 2008;299(5):532–539.
   PubMed Web of Science ®Google Scholar
• Ong ATL, McFadden EP, Regar E, et al. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol. 2005;45(12):2088–2092.
   PubMed Web of Science ®Google Scholar
• Pfisterer M, Brunner-La Rocca HP, Buser PT, BASKET-LATE Investigators, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol. 2006;48(12):2584–2591.
   PubMed Web of Science ®Google Scholar
• Beigel R, Mazin I, Koifman E, et al. Aspirin withdrawal in patients treated with ticagrelor presenting with non-ST elevation myocardial infarction. J Thromb Haemost. 2018;16(4):663–669.
   PubMed Web of Science ®Google Scholar